CSIMarket
 
Vir Biotechnology Inc   (VIR)
Other Ticker:  
 
 

Vir Biotechnology Inc Growth Comparisons

Select each growth Category to receive further Information



VIR Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -10.45 % -1.03 % 2.15 % 3.02 %
Q / Q Revenue Growth (Q1 MRQ) 235.83 % -19.09 % -2.96 % -2.06 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -82.16 % -7.73 % -0.03 % %
Seq. Revenue Growth (for 12 months ending Q1 TTM) -7.64 % -0.4 % 0.22 % 0.69 %
Revenue 5 Year Average Growth - 7.39 % 8.29 % 8.07 %


VIR's Growth Comparisons in I. Quarter 2024




Vir Biotechnology Inc reported sharp sales fall by -10.45% from the same quarter a year ago, in the first quarter 2024, despite the minor sales decline in the Biotechnology & Pharmaceuticals industry by -1.03%, and underperformed the 2.15% Revenue growth in the Healthcare sector. Weak first quarter sales, in Biotechnology & Pharmaceuticals industry and within the Healthcare sector, were reflected in Vir Biotechnology Inc results which underperformed overall market.

Company's sequential Revenue growth rate was impressive 235.83% from the forth quarter. Average yearly sales growth for Vir Biotechnology Inc is %, while S & P 500's average annual sales growth is 8.07% over the five years, including only Businesses with the first quarter 2024 financial reports.


Growth Rates of VIR's Income in the first quarter 2024


VIR Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - - -50.1 % 5.84 %
Seq. Operating Income Change (Q1 MRQ) - - 32.38 % 8.66 %
Y / Y Operating Income Growth (Q1 TTM) - -94.51 % -62.97 % -5.56 %
Seq. Operating Income Growth (Q1 TTM) - -85.78 % -28.13 % 1.84 %
Operating Income 5 Year Avg. Change - -20.68 % -1.07 % 9.38 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - - -69.27 % -5.37 %
Seq. Income from Cont. Ops. Change (Q1 MRQ) - - -63.2 % 7.08 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - - -75.02 % -7.26 %
Seq. Income from Cont. Ops. Change (Q1 TTM) - - -41.38 % -1.36 %
Income from Cont. Ops. 5 Year Avg. Change - -27.02 % -6.37 % 6.88 %

VIR Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - - -69.27 % -5.46 %
Q / Q Net Income Growth (Q1 MRQ) - - -63.61 % 10.02 %
Y / Y Net Income Change (Q1 TTM) - - -48.48 % -5.89 %
Seq. Net Income Change (Q1 TTM) - - -25.19 % -1.37 %
Net Income 5 Year Avg. Growth - -27.01 % -0.75 % 7.08 %

VIR's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - - -69.27 % -5.37 %
Seq. EPS from Cont. Ops. Change (Q1 MRQ) - - -63.2 % 7.08 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Seq. EPS from Cont. Ops. Change (Q1 TTM) - - - 45.9 %
EPS from Cont. Ops. 5 Year Avg. Growth - -33.75 % -6.37 % 6.88 %



VIR EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - - -69.27 % -5.46 %
Q / Q EPS Net Growth (Q1 MRQ) - - -63.61 % 10.02 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 99100.16 %
Seq. EPS Net Change (for 12 months ending Q1 TTM) - - - 46.16 %
EPS Net 5 Year Avg. Change - -27.01 % -0.75 % 7.08 %



Vir Biotechnology Inc reported bottom-line of $ -0.48 in the first quarter, compare to $ -1.06 in the same quarter a year ago. Biotechnology & Pharmaceuticals industry fell by -1.03%, while Healthcare sector decreased by -69.27%, and overall market declined by -5.46%.

The Company's sequential EPS growth rate was very impressive 235.83% from the forth quarter. Average yearly income per share growth for Vir Biotechnology Inc is %, while S & P 500's average annual income per share growth is 7.08% over the five years, including only Businesses with the first quarter 2024 earnings results.

VIR Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 119.77 % 5.56 % -51.5 %
Seq. Free Cash Flow Change (Q1 MRQ) - -33.63 % -42.35 % -84.35 %
Y / Y Free Cash Flow Change (Q1 TTM) - -34.96 % -6.02 % -6.74 %
Seq. Free Cash Flow Change (Q1 TTM) - 5.84 % 0.21 % -4.98 %
Free Cash Flow 5 Year Avg. Change - -13.51 % 9.02 % 12.33 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - -78.69 % -
Seq. Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) - - - -
Seq. Net Cash Flow Change (Q1 TTM) - - - -
Net Cash Flow 5 Year Avg. Change - 3.56 % 9.01 % -33.88 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -72.74 % -7 % -4.98 % 5.04 %
Seq. Capital Expenditures Change (Q1 MRQ) 21.95 % -11.43 % -22.65 % -14.8 %
Y / Y Capital Expenditures Change (Q1 TTM) -71.93 % 14.42 % 1.46 % 20.14 %
Seq. Capital Expenditures Change (Q1 TTM) -23.15 % -2.25 % -1.53 % -0.28 %
Capital Expenditures 5 Year Avg. Change - -3.18 % 9.36 % 10.16 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com